<DOC>
	<DOCNO>NCT00139555</DOCNO>
	<brief_summary>Left ventricular hypertrophy ( LVH ) increase risk cardiovascular morbidity mortality patient high blood pressure , compare without LVH . Reduction leave ventricular mass ( LVM ) antihypertensive agent associate improved clinical outcome . This study evaluate effect amlodipine/benazepril reduce LVM patient high risk hypertension .</brief_summary>
	<brief_title>Effects Amlodipine/Benazepril Reducing Left Ventricular Hypertrophy Patients With High Risk Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Males female patient â‰¥ 55 year age LVH confirm echocardiogram Patients high risk hypertension , currently treat already take antihypertensive medication Renal artery stenosis Symptomatic heart failure know ejection fraction &lt; 40 % Myocardial infarction stroke within 6 month Presence cranial aneurysm clip , coronary artery metal stent pacemaker Pregnant lactate female Cancer within last 5 year</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Left ventricular hypertrophy</keyword>
</DOC>